Edition:
India

Sinovac Biotech Ltd (SVA.OQ)

SVA.OQ on NASDAQ Stock Exchange Global Select Market

6.47USD
22 Feb 2019
Change (% chg)

-- (--)
Prev Close
$6.47
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,385
52-wk High
$8.67
52-wk Low
$5.73

About

Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1)... (more)
No analyst recommendations are available for .

Overall

Beta: 0.08
Market Cap(Mil.): $399.48
Shares Outstanding(Mil.): 56.91
Dividend: --
Yield (%): --

Financials

  SVA.OQ Industry Sector
P/E (TTM): -- 29.30 32.55
EPS (TTM): -0.11 -- --
ROI: -6.06 14.23 13.83
ROE: -5.15 15.46 15.25

Sinovac Biotech activates 'poison pill' defense in rare move

Sinovac Biotech Ltd, a Nasdaq-listed Chinese vaccine developer, activated a shareholders rights plan on Friday, according to a press release seen by Reuters, the first time a company has used a "poison pill" takeover defense in more than a decade.

23 Feb 2019

Sinovac Biotech activates 'poison pill' defense in rare move

Feb 22 Sinovac Biotech Ltd, a Nasdaq-listed Chinese vaccine developer, activated a shareholders rights plan on Friday, according to a press release seen by Reuters, the first time a company has used a "poison pill" takeover defense in more than a decade.

23 Feb 2019

Earnings vs. Estimates